JP2022520410A5 - - Google Patents

Info

Publication number
JP2022520410A5
JP2022520410A5 JP2021547248A JP2021547248A JP2022520410A5 JP 2022520410 A5 JP2022520410 A5 JP 2022520410A5 JP 2021547248 A JP2021547248 A JP 2021547248A JP 2021547248 A JP2021547248 A JP 2021547248A JP 2022520410 A5 JP2022520410 A5 JP 2022520410A5
Authority
JP
Japan
Prior art keywords
compound
crystalline form
crystalline
peaks
ray diffraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021547248A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022520410A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/051212 external-priority patent/WO2020165840A1/en
Publication of JP2022520410A publication Critical patent/JP2022520410A/ja
Publication of JP2022520410A5 publication Critical patent/JP2022520410A5/ja
Priority to JP2024128919A priority Critical patent/JP2024161426A/ja
Priority to JP2025148623A priority patent/JP2026004320A/ja
Pending legal-status Critical Current

Links

JP2021547248A 2019-02-15 2020-02-13 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤 Pending JP2022520410A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024128919A JP2024161426A (ja) 2019-02-15 2024-08-05 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤
JP2025148623A JP2026004320A (ja) 2019-02-15 2025-09-08 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962806697P 2019-02-15 2019-02-15
US62/806,697 2019-02-15
PCT/IB2020/051212 WO2020165840A1 (en) 2019-02-15 2020-02-13 Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024128919A Division JP2024161426A (ja) 2019-02-15 2024-08-05 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤

Publications (2)

Publication Number Publication Date
JP2022520410A JP2022520410A (ja) 2022-03-30
JP2022520410A5 true JP2022520410A5 (https=) 2023-02-16

Family

ID=69740425

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021547248A Pending JP2022520410A (ja) 2019-02-15 2020-02-13 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤
JP2024128919A Pending JP2024161426A (ja) 2019-02-15 2024-08-05 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤
JP2025148623A Pending JP2026004320A (ja) 2019-02-15 2025-09-08 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024128919A Pending JP2024161426A (ja) 2019-02-15 2024-08-05 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤
JP2025148623A Pending JP2026004320A (ja) 2019-02-15 2025-09-08 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤

Country Status (5)

Country Link
US (1) US12600702B2 (https=)
EP (2) EP4431497A1 (https=)
JP (3) JP2022520410A (https=)
CN (1) CN113423696A (https=)
WO (1) WO2020165840A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210129677A (ko) * 2019-02-15 2021-10-28 노파르티스 아게 안구 표면 통증의 치료 방법
WO2022029656A1 (en) * 2020-08-06 2022-02-10 Novartis Ag Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof
WO2022105792A1 (zh) * 2020-11-17 2022-05-27 苏州晶云药物科技股份有限公司 一种喹唑啉酮衍生物的新晶型及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931319A (en) 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4525346A (en) 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4836986A (en) 1984-09-28 1989-06-06 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
US5037647A (en) 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
US5145643A (en) 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5300287A (en) 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
GB0412769D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
US8349852B2 (en) * 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
EP3470059B1 (en) * 2015-01-26 2020-04-01 Bausch & Lomb Incorporated Ophthalmic suspension composition
WO2022029656A1 (en) * 2020-08-06 2022-02-10 Novartis Ag Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof

Similar Documents

Publication Publication Date Title
JP2022520410A5 (https=)
JP2022081661A5 (https=)
JP2023171614A5 (https=)
HU213211B (en) Process for producing new physical modification of n-/4-(5-(cyclopentyl oxycarbonyl)amino-1-methylindol-3-yl-methyl)-3-methoxybenzoyl/-2-methyl benzenesulphonamide and pharmaceutical compositions comprising the same
JP2023512763A5 (https=)
JP2024544538A5 (https=)
JP2025179094A5 (https=)
JP2009143954A (ja) チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
JP2020073513A (ja) α，ω‐二置換ジヒドロキシシクロペンチル化合物の固体形態、並びにその製造及び使用方法
HUP0100500A2 (hu) Az 5-[4-{2-[N-metil-N-(2-piridil)-amino]-etoxi}-benzil]-2,4-dioxo-tiazolidin-maleinsav-só hidrátja, eljárás az előállításukra és gyógyászati alkalmazása
CN111670189A (zh) 对rsv具有活性的环烷基取代的吡唑并嘧啶
JP4342304B2 (ja) チアゾリルアミドの局所適用
WO2002045750A1 (en) Combination drugs
JP2025506783A5 (https=)
JP2024539623A5 (https=)
JP2023536938A5 (https=)
CA2522666A1 (en) Combination therapies for chronic obstructive pulmonary disease (copd)
JP2024524933A5 (https=)
BG65428B1 (bg) Тиазолидиндионово производно, метод за получаването му, фармацевтичен състав и използването му катоантидиабетик
DE10129716A1 (de) Kombinationspräparate zur Herpes-Behandlung
JP2012250953A (ja) アデノシン誘導体とα２受容体作動薬の組合せ剤
WO2019124487A1 (ja) オミデネパグの組合せ
TW201609788A (zh) 類固醇樣化合物之多晶型形式以及其製備方法及用途
US9387196B2 (en) 3-{1-[5-chloro-2-(2-ethylbutoxy)benzyl]-5-methyl-1H-pyrazol-3-yl}propanoic acid in crystalline form and methods for use thereof
JP2014524935A (ja) Ｎ，ｎ−ジアルキルアルキレニルエステル類、その組成物およびその使用方法